Endocrine Testing Market is Estimated to Progress at a CAGR of 6.4% during the Forecast Period, notes TMR Study

Transparency Market Research

An ageing person's hormone levels are affected by several changes to organs and endocrine glands, therefore the expanding geriatric populace is likely to propel the global endocrine testing market

Wilmington, Delaware, United States, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The value of the global endocrine testing market stood at US$ 5.5 Bn in 2018. The global market study on endocrine testing expects the market to rise at a CAGR of 6.4% during the forecast period, from 2019 to 2027. The global market for endocrine testing is expected to expand faster as metabolic and endocrine problems become more common. The market is also anticipated to develop as diabetes prevalence rise across the globe.

Endocrine glands, which are a component of the endocrine system, produce hormones right into the bloodstream. Testing is done to check the levels of endocrine hormones in biological samples, including luteinizing hormone, follicle stimulating hormone, insulin, estradiol, and many others. These tests assist identify deviations in hormone secretion, such as hypersecretion or hyposecretion, which can lead to endocrine illnesses such as menopause, infertility, thyroid dysfunction, and various other conditions. Ongoing trends of the endocrine testing market

Endocrine testing has increased as a result of a number of illnesses, including various forms of diabetes and PCOS and it is also expected to present positive endocrine testing market outlook. For instance, a study reported in Current Diabetes Reports found a substantial increase in the incidence of PCOS and diabetes. Therefore, the rise in endocrine and metabolic diseases is a major driver that is predicted to fuel the expansion of the global endocrine testing market in the years to come.

Get Exclusive PDF Sample Copy of Endocrine Testing Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1645

Key Findings of Market Report

• The prevalence and severity of diabetes are increasing as a result of sedentary lifestyles and poor diets. A study found that there were 463 million people living with diabetes worldwide in 2019 and that number is expected to rise to 578 million by 2030, based on an article that appeared in Diabetes Research and Clinical Practice. The demand for innovative testing techniques that produce quick responses is rising as a result. Endocrine testing market revenue analysis observe that major companies are spending on R&D operations to design and develop solutions utilizing new technologies to meet these needs. This factor is expected to come up as one of the ongoing trends of the endocrine testing markets.
  
  

• The constant increase in the number of elderly people throughout the world has a direct impact on the development of endocrine testing techniques and solutions. This is due to the fact that this group is particularly vulnerable to a variety of health issues and demands efficient disease management on a global scale. One risk factor for thyroid problems, hernia, as well as other hormone abnormalities is old age and it is expected to present promising growth opportunities to the companies in the endocrine testing market.
  

Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=1645

Global Endocrine Testing Market: Key Players

Some of the key market players are

• Thermo Fisher Scientific

• F-Hoffmann La Roche Ltd

• Beckman Coulter Inc.

• Bio-Rad Laboratories, Inc.

• Agilent Technologies, Inc.

• bioMérieux SA

Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1645

Global Endocrine Testing Market: Segmentation

Test Type

• Estradiol (E2) Test

• Follicle Stimulating Hormone (FSH) Test

• Human Chorionic Gonadotropin (hCG) Test

• Luteinizing Hormone (LH) Test

• Dehydroepiandrosterone sulfate (DHEAS) Test

• Progesterone Test

• Testosterone Test

• Thyroid Stimulating Hormone (TSH) Test

• Prolactin Test

• Cortisol Test

• Insulin Test

• Others

Diagnostic Technologies

• Tandem Mass Spectrometry

• Immunoassay technologies

• Monoclonal and Polyclonal Antibody Technologies

• Sensor Technologies

• Clinical Chemistry Technologies
  

End User

• Commercial Laboratories

• Ambulatory Care Centers

• Home Based tests

• Physician Offices

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:

Brachytherapy Devices Market: The brachytherapy applicators segment is estimated to expand at a CAGR of 8.4% and account for the dominant share of the brachytherapy devices market during the forecast period.

Hyperbaric Oxygen Therapy Devices Market: The global hyperbaric oxygen therapy devices market is expected to reach the value of US$ 7.3 Bn by the end of 2028.

IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market: The global IBD (ulcerative colitis and Crohn's disease) treatment market was valued at ~US$ 15.5 Bn in 2018 and is projected to expand at a CAGR of ~6% from 2019 to 2027.

Hemophilia Treatment Drugs Market: The global hemophilia treatment drugs market was valued at US$ 9,500 Mn in 2017 and is anticipated to reach US$ 15,000 Mn by 2026, expanding at a CAGR of 5% from 2018 to 2026.

Critical Limb Ischemia Treatment Market: The global critical limb ischemia treatment market is driven by rise in prevalence of critical limb ischemia. Growth of the market is also attributed to increase in awareness about critical limb ischemia and rich product pipeline.

Menopausal Hot Flashes Treatment Market: Growing population of elderly women worldwide coupled with rise in menopausal hot flashes symptoms is a major factor responsible for the growth of global menopausal hot flashes treatment market.

Substance Abuse Treatment Market: The global substance abuse treatment market is anticipated to cross US$ 23.1 Bn by 2031. The global market is projected to grow at a CAGR of 8.5% from 2022 to 2031.

Glioblastoma Multiforme Treatment (GBM) Market: The global glioblastoma multiforme (GBM) treatment market is expected to reach the value of US$ 3.72 Bn by the end of 2028.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com